scholarly article | Q13442814 |
P50 | author | Roger G Ptak | Q90694284 |
William Fu | Q115679043 | ||
P2093 | author name string | Vinay K Pathak | |
Wei-Shau Hu | |||
Kunio Nagashima | |||
Ferri Soheilian | |||
Michael D Moore | |||
P2860 | cites work | Active human immunodeficiency virus protease is required for viral infectivity | Q24647696 |
Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates | Q24812175 | ||
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. | Q29619254 | ||
Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events | Q33716831 | ||
Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. | Q33845445 | ||
The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner | Q34104639 | ||
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease | Q34288376 | ||
Effects of Gag mutation and processing on retroviral dimeric RNA maturation | Q34302140 | ||
The stoichiometry of Gag protein in HIV-1. | Q34328141 | ||
The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein. | Q34999802 | ||
Effects of blocking individual maturation cleavages in murine leukemia virus gag. | Q35542805 | ||
Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA | Q35823493 | ||
Structure of B77 sarcoma virus RNA: stabilization of RNA after packaging | Q36568149 | ||
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions | Q36624873 | ||
The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. | Q36636632 | ||
Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. | Q36650046 | ||
Maturation of dimeric viral RNA of Moloney murine leukemia virus. | Q36652049 | ||
HIV-1 protease: structure, dynamics, and inhibition | Q36857092 | ||
PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing | Q37089562 | ||
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro | Q37427179 | ||
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 | Q39612212 | ||
Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein | Q39748566 | ||
Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. | Q40115512 | ||
Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. | Q40326740 | ||
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly | Q41047831 | ||
Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism | Q41275889 | ||
Image reconstructions of helical assemblies of the HIV-1 CA protein | Q41631451 | ||
Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease | Q41997191 | ||
Ultrastructure of human retroviruses | Q44966201 | ||
Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. | Q47314618 | ||
New hope in HIV disease | Q47627157 | ||
Immunologic and Ultrastructural Characterization of HIV Pseudovirions Containing Gag and Env Precursor Proteins Engineered in Insect Cells | Q52550200 | ||
A procedure for Northern blot analysis of native RNA | Q68984616 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | morphogenesis | Q815547 |
virion | Q1757347 | ||
P304 | page(s) | 152-160 | |
P577 | publication date | 2008-07-26 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation | |
P478 | volume | 379 |
Q41730903 | A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro |
Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
Q27677515 | Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation |
Q51082089 | Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Rats with S-Allyl Cysteine. |
Q33761008 | Cryo electron tomography of native HIV-1 budding sites |
Q28743199 | Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1) |
Q31106756 | Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine. |
Q37447762 | HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. |
Q57459053 | Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation |
Q35477673 | Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein |
Q37574479 | Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors |
Q36414162 | Novel two-round phenotypic assay for protease inhibitor susceptibility testing of recombinant and primary HIV-1 isolates. |
Q40732172 | RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly |
Q45388085 | Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization |
Q35073452 | Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle |
Q35215018 | The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome |
Q39615571 | The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity |
Search more.